<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181438</url>
  </required_header>
  <id_info>
    <org_study_id>TAP Block Renal Transplant</org_study_id>
    <nct_id>NCT03181438</nct_id>
  </id_info>
  <brief_title>Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery</brief_title>
  <official_title>Efficacy of Ultrasound-guided Transverse Abdominal Plane Block for Analgesia in Renal Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the efficacy and safety of transverse abdominal
      plane block in patients undergoing renal transplant surgery.Adult renal transplant recipients
      will be prospectively randomized to receive a standard general anesthetic technique
      supplemented with ropivacaine 0.375% 20 mL TAP block or sham block with 20 mL 0.9% saline.
      Both groups will receive patient-controlled morphine analgesia. Patient assessment will occur
      in the postanesthetic care unit and at 1, 2, 4, 6, 12, and 24 hours. The primary outcome is
      total morphine consumption in the first 24 hours after renal transplantation. Other outcomes
      asses include pain scores, presence of nausea or vomiting, excessive sedation, and
      respiratory depression.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2017</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine Consumption</measure>
    <time_frame>24 hours post-operative</time_frame>
    <description>Patient Control Analgesia: morphine sulfate 2 mg IV every 5 minutes until visual analog scale pain score (0 = no pain, 10 = worst possible pain) is 3 or less, and continued at the following settings for a 24-hour period: 1 mg bolus, 7-minute lockout, and 30 mg maximum 4-hourly dose.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>24 hours post-operative</time_frame>
    <description>Visual analogue score (VAS) at rest and movement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <condition>Acute Pain</condition>
  <condition>Kidney Transplantation</condition>
  <condition>Anesthesia, Conduction</condition>
  <arm_group>
    <arm_group_label>TAP Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The TAP block will be performed under general anesthesia, according to the technique described below:
The patient will be placed supine with the abdomen exposed between the iliac crest and the costal margin
After skin antisepsis, a high-frequency ultrasound transducer will be placed transversely across the anterior axillary line above the iliac crest
In this region, the abdominal musculature (external oblique, internal oblique and transverse abdomen) is identified, and the transverse abdominal plane of the abdomen
The needle (BD-A-50mm) will be inserted in the technique &quot;in plane&quot; to the region of the transverse plane of the abdomen, where the solution will be administered.
In this group, will be administered 20 mL of 0.375% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The block will be performed under general anesthesia, according to the technique described below:
The patient will be placed supine with the abdomen exposed between the iliac crest and the costal margin
After skin antisepsis, a high-frequency ultrasound transducer will be placed transversely across the anterior axillary line above the iliac crest
In this region, the abdominal musculature (external oblique, internal oblique and transverse abdomen) is identified, and the transverse abdominal plane of the abdomen
The needle (BD-A-50mm) will be inserted in the technique &quot;in plane&quot; to the region of the transverse plane of the abdomen, where the solution will be administered.
In this group, will be administered 20 mL of Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TAP Block</intervention_name>
    <description>It will be performed a ultrasound-guided transverse abdominal plane block with 20 ml of 0.375% of ropivacaine for patients submitted to renal transplantation</description>
    <arm_group_label>TAP Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline Group</intervention_name>
    <description>t will be performed a ultrasound-guided transverse abdominal plane block with 2o mL of saline for patients submitted to renal transplantation</description>
    <arm_group_label>Saline Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  end-stage renal disease undergoing cadaveric renal transplantation

        Exclusion Criteria:

          -  Contraindications to the use of morphine

          -  Contraindications to the use ropivacaine

          -  Peripheral neuropathy

          -  Inability to use a Patient Control Analgesia device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonardo HC Ferraro, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leonardo HC Ferraro, Professor</last_name>
    <phone>+ 55 11 999516103</phone>
    <email>leohcferraro1@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital do Rim e Hipertensao</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04038-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonardo HC Ferraro, Professor</last_name>
      <phone>+ 55 11 99951-6103</phone>
      <email>leohcferraro1@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011 Jun 25;377(9784):2215-25. doi: 10.1016/S0140-6736(11)60245-6. Review.</citation>
    <PMID>21704871</PMID>
  </results_reference>
  <results_reference>
    <citation>Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004 Nov;28(5):497-504. Review.</citation>
    <PMID>15504625</PMID>
  </results_reference>
  <results_reference>
    <citation>Finnerty O, Carney J, McDonnell JG. Trunk blocks for abdominal surgery. Anaesthesia. 2010 Apr;65 Suppl 1:76-83. doi: 10.1111/j.1365-2044.2009.06203.x. Review.</citation>
    <PMID>20377549</PMID>
  </results_reference>
  <results_reference>
    <citation>McDonnell JG, O'Donnell BD, Farrell T, Gough N, Tuite D, Power C, Laffey JG. Transversus abdominis plane block: a cadaveric and radiological evaluation. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):399-404.</citation>
    <PMID>17961838</PMID>
  </results_reference>
  <results_reference>
    <citation>Rafi AN. Abdominal field block: a new approach via the lumbar triangle. Anaesthesia. 2001 Oct;56(10):1024-6.</citation>
    <PMID>11576144</PMID>
  </results_reference>
  <results_reference>
    <citation>Warman P, Nicholls B. Ultrasound-guided nerve blocks: efficacy and safety. Best Pract Res Clin Anaesthesiol. 2009 Sep;23(3):313-26. Review.</citation>
    <PMID>19862890</PMID>
  </results_reference>
  <results_reference>
    <citation>Niraj G, Searle A, Mathews M, Misra V, Baban M, Kiani S, Wong M. Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth. 2009 Oct;103(4):601-5. doi: 10.1093/bja/aep175. Epub 2009 Jun 26.</citation>
    <PMID>19561014</PMID>
  </results_reference>
  <results_reference>
    <citation>Mukhtar K, Khattak I. Transversus abdominis plane block for renal transplant recipients. Br J Anaesth. 2010 May;104(5):663-4. doi: 10.1093/bja/aeq077.</citation>
    <PMID>20400617</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>June 7, 2017</last_update_submitted>
  <last_update_submitted_qc>June 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Leonardo Henrique Cunha Ferraro</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Renal Transplantation</keyword>
  <keyword>Acute pain</keyword>
  <keyword>Regional Anesthesia</keyword>
  <keyword>TAP Block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

